Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 04/24/2023 | FIFTH THIRD BANCORP | 0 | $0 | -100.00% | 0.00% |
| 05/12/2023 | STIFEL FINANCIAL CORP | 0 | $0 | -100.00% | 0.00% |
| 05/15/2023 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 0.00% |
| 05/11/2023 | CITIGROUP INC | 0 | $0 | -100.00% | 0.00% |
| 05/15/2023 | MORGAN STANLEY | 0 | $0 | -100.00% | 0.00% |
| 04/12/2023 | NATIONAL BANK OF CANADA /FI/ | 0 | $0 | -100.00% | 0.00% |
| 05/12/2023 | BNP PARIBAS ARBITRAGE, SNC | 0 | $0 | -100.00% | 0.00% |
| 05/16/2023 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0 | $0 | -100.00% | 0.00% |
| 05/15/2023 | TWO SIGMA SECURITIES, LLC | 0 | $0 | -100.00% | 0.00% |
| 05/12/2023 | UBS GROUP AG | 0 | $0 | -100.00% | 0.00% |
| 11/13/2023 | TD WATERHOUSE CANADA INC. | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 1 institutional investors and hedge funds held shares of Can-Fite BioPharma Ltd.. The most heavily invested institutionals were:
American Portfolios Advisors: 1,100
A. Institutional investors have bought a total of 1,100 shares in the last 24 months. This purchase volume represents approximately $2,662 in transactions.
